Stacy Chick appointed Chief Commercial Officer at Inivata

Stacy Chick was recently appointed as Chief Commercial Officer at Inivata, a global leader in liquid biopsy with laboratories in Research Triangle Park, NC and Cambridge UK. Stacy Chick joined Inivata to commercialize InVisionFirst(TM) Lung which provides molecular insights that enable clinicians to make more informed targeted treatment choices for patients with advanced NSCLC. Stacy Chick leads the commercial organization which includes global sales, marketing, market access and communications.

Prior to joining Inivata, Stacy Chick held executive leadership roles in sales, marketing and market access among several public and privately-held life science companies including Bristol-Myers Squibb, Sanofi, UCB and Archimedes Pharma. In these roles Stacy Chick led teams which collaboratively built and implemented pre-launch to end-of-life cycle strategies spanning every US healthcare channel and among multiple therapeutic areas. Throughout her career, Stacy has been recognized for her collaborative approach in delivering exceptional business results in challenging market conditions while earning multiple individual and team leadership awards.

Stacy Chick earned her MBA in Finance from Rutgers University (Newark NJ) and her BBA in Marketing from the University of Georgia (Athens GA.) She is a member of the International Association for the Study of Lung Cancer (IASLC), Women Business Leaders (WBL), Healthcare Businesswomen’s Association (HBA), Leukemia and Lymphoma Society, Soldiers Angels, Alpha Omicron Pi Alumna and the University of Georgia Terry College of Business Alumni Board (Emeritus.) Previously Stacy Chick served as a full-time caregiver and patient advocate to a family member with a rare blood cancer and, drawing upon that experience, she was named as a Peer Ambassador at Emory Winship Cancer Center and as a Board Member of Our Brain Bank, a 501©3 organization supporting glioblastoma patients, their caregivers and healthcare professionals.